"Bulletin","Class_of_antibiotics","Antibiotic","Isolated","Resistance","95_IC_low","95_IC_upper"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2021.pdf","Penicilline","Ampicillina",7023,"1.3","1.0","1.6"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2021.pdf","Aminoglicosidi (alto dosaggio)","Gentamicina",3029,"36.4","34.7","38.2"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2021.pdf","Aminoglicosidi (alto dosaggio)","Streptomicina",3798,"34.7","33.2","36.3"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2021.pdf","Glicopeptidi","Vancomicina",6915,"1.5","1.2","1.8"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2021.pdf","Glicopeptidi","Teicoplanina",6768,"1.6","1.3","2.0"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2021.pdf","Ossazolidinioni","Linezolid",6863,"0.5","0.3","0.7"
